Q-VANT is a privately held company that has solved the supply chain problem of QS-21 and other Quillaja-based saponin adjuvants for the global human and animal pharmaceutical markets. The company’s next-generation technology platform combines computational learning techniques with a proprietary multi-step purification process to increase the supply of QS-21 by more than 1,000 – enabling the production of billions of doses annually to meet today’s increasing global market demand. Led by a team with unrivalled experience in vaccine and adjuvant development, manufacturing and global regulatory requirements, and with world-class knowledge in Quillaja saponin supply chain, agronomy, extraction and purification, Q-VANT is the first company that is vertically integrated to combine a secured sustainable Quillaja raw material supply with pharma cGMP commercial-scale production of QS-21 and other saponin-based adjuvants. For more information, visit www.q-vant.com.
Company Details
- Employees
- 16
- Founded
- -
- Address
- 3 Haley Way, Forestdale, Forestdale,massachusetts 02644,united States
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- https://q-vant.com/
- Keywords
- in LC/MS/MS and GC/MS.
- HQ
- Forestdale, Massachusetts
Q-Vant Biosciences Questions
Q-Vant Biosciences's website is https://q-vant.com/
Q-Vant Biosciences's LinkedIn profile is https://www.linkedin.com/company/q-vant
Q-Vant Biosciences has
16 employees.
View email and phone details for 16
employees at Q-Vant Biosciences.
Q-Vant Biosciences's industry is
Pharmaceutical Manufacturing
Q-Vant Biosciences's top competitors are
Biolaunch,
Inimmune,
Desert King,
Dynavax Technologies,
Spi Pharma,
Botanical Solution,
Synthon Chile,
Maxcyte, Inc.,
Plantae Labs,
Zocdoc.
Q-Vant Biosciences's categories are Pharmaceutical Manufacturing
Q-Vant Biosciences's founding year is 2019
